FIELD: medicine; surgery.
SUBSTANCE: for prevention of adhesive obstruction evolving during peritonitis, Splenopid medicine is introduced into abdominal cavity at the end of operation.
EFFECT: prevention of adhesive obstruction development during peritonitis due to cytokines included in the medicine.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING INTESTINAL DYSBACTERIOSIS IN PERITONITIS CASES | 2005 |
|
RU2283120C1 |
| METHOD FOR TREATING THE CASES OF COMMISSURE DISEASE | 1998 |
|
RU2177741C2 |
| METHOD OF PREVENTING POSTOPERATIVE COMMISSURAL PROCESS IN ABDOMINAL CAVITY | 2009 |
|
RU2432944C2 |
| METHOD FOR TREATMENT OF EXTENSIVE PERITONITIS | 2007 |
|
RU2339368C1 |
| METHOD OF PREVENTION OF COMMISSURE FORMATION AND RELAPSE THEREOF | 2007 |
|
RU2331367C1 |
| METHOD OF PREVENTING RECURRENCE OF PERITONEAL COMMISSURES IN PATIENTS WITH TUBE-PERITONEAL FORM OF INFERTILITY | 2010 |
|
RU2445028C2 |
| METHOD FOR PREVENTION OF ABDOMINAL ADHESION FORMATION FOLLOWING INTRA-ABDOMINAL OPERATIONS | 2012 |
|
RU2540463C2 |
| METHOD OF DECOMPRESSION AND INTERIOR SPLINTING AT FUNCTIONAL INTENSTINE OBSTRUCTION | 0 |
|
SU933082A1 |
| METHOD FOR TREATMENT PERITONITIS | 1993 |
|
RU2092111C1 |
| METHOD FOR PREVENTING VISCEROPARIETAL ABDOMINAL COMMISSURES | 1998 |
|
RU2150897C1 |
